WeCure Pharma Nordic ApS: Financial statements 2021
CVR: 41349751
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
WeCure Pharma Nordic ApS (CVR 41349751) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 5,504 and a net result of DKK 3,875. Equity in the 2021 report amounted to DKK 37,003. The solvency ratio was 84%.
- Gross Profit
- DKK 5,504
- Profit/Loss
- DKK 3,875
- Equity
- DKK 37,003
- Total Assets
- DKK 44,067
Official annual report
Find more companies like WeCure Pharma Nordic ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
WeCure Pharma Nordic ApS has published its interim report for the period May 5, 2020 – December 31, 2020.
About WeCure Pharma Nordic ApS
WeCure Pharma Nordic ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company has been dissolved on 14 May 2024. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. In 2022, the company reported a gross profit of DKK 15,442 and a net result of DKK 11,742 compared with DKK 3,875 the year before. Equity in the 2022 report amounted to DKK 48,745.